Get started
Divi's Laboratories LimitedDivi's Laboratories LimitedDivi's Laboratories Limited

Divi's Laboratories Limited

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Divi's Laboratories Limited



Key stats


Market capitalization
‪2.42 T‬ INR
Dividend yield (indicated)
0.32%
Price to earnings Ratio (TTM)
82.5
Basic EPS (TTM)
110.0 INR
Net income (FY)
‪25.68 B‬ INR
Revenue (FY)
‪105.48 B‬ INR
Shares float
‪127.37 M‬
Beta (1Y)
0.83

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪19.29 K‬
Change (1Y)
+987+5.39%
Revenue / Employee (1Y)
‪5.47 M‬ INR
Net income / Employee (1Y)
‪1.33 M‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Satchandra Kiran Divi
Website
divislabs.com
Headquarters
Hyderabad
Founded
1990
IPO date
Jun 25, 1905
ISIN
INE361B01024
FIGI
BBG000DJVYM0
Identifiers
ISIN INE361B01024
CFI code
ESVUFN
Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates, and nutraceuticals. It also provides manufacturing of generic APIs, nutraceutical ingredients, and custom synthesis for big pharma. It operates through the following segments: Generic API, Custom Synthesis, and Nutraceuticals. The company was founded by Murali Krishna Prasad Divi on October 12, 1990 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.02%
Market value‪158.58 M‬
VWO
Vanguard FTSE Emerging Markets ETF
Weight0.09%
Market value‪150.68 M‬
IEMG
iShares Core MSCI Emerging Markets ETF
Weight0.08%
Market value‪130.46 M‬
INDA
iShares MSCI India ETF
Weight0.82%
Market value‪54.94 M‬
IIND
iShares MSCI India UCITS ETF
Weight0.83%
Market value‪43.09 M‬
EIMI
iShares Core MSCI EM IMI UCITS ETF
Weight0.09%
Market value‪40.71 M‬
EIMU
iShares Core MSCI EM IMI UCITS ETF
Weight0.09%
Market value‪40.71 M‬
JUNIORBEES
Nippon India ETF Nifty Next 50 Junior BeES
Weight4.03%
Market value‪36.64 M‬
EEM
iShares MSCI Emerging Index Fund
Weight0.09%
Market value‪29.40 M‬
EMXC
iShares MSCI Emerging Markets ex China ETF
Weight0.11%
Market value‪29.03 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.03%
Market value‪25.41 M‬

Explore more ETFs 

Frequently asked questions


The current price of DIVISLAB is 9,575.0 INR — it has increased by 0.92% in the past 24 hours. Watch Divi's Laboratories Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Divi's Laboratories Limited stocks are traded under the ticker DIVISLAB.
DIVISLAB stock has risen by 1.61% compared to the previous week, the month change is a 13.46% rise, over the last year Divi's Laboratories Limited has showed a 58.82% increase.
We've gathered analysts' opinions on Divi's Laboratories Limited future price: according to them, DIVISLAB price has a max estimate of 11,700.00 INR and a min estimate of 5,227.00 INR. Watch DIVISLAB chart and read a more detailed Divi's Laboratories Limited stock forecast: see what analysts think of Divi's Laboratories Limited and suggest that you do with its stocks.
DIVISLAB reached its all-time high on Aug 31, 2026 with the price of 9,467.0 INR, and its all-time low was 8.0 INR and was reached on Mar 12, 2003. View more price dynamics on DIVISLAB chart.
See other stocks reaching their highest and lowest prices.
DIVISLAB stock is 3.62% volatile and has beta coefficient of 0.83. Track Divi's Laboratories Limited stock price on the chart and check out the list of the most volatile stocks — is Divi's Laboratories Limited there?
Today Divi's Laboratories Limited has the market capitalization of ‪2.47 T‬, it has increased by 1.66% over the last week.
Yes, you can track Divi's Laboratories Limited financials in yearly and quarterly reports right on TradingView.
Divi's Laboratories Limited is going to release the next earnings report on Nov 9, 2026. Keep track of upcoming events with our Earnings Calendar.
DIVISLAB earnings for the last quarter are 33.95 INR per share, whereas the estimation was 25.39 INR resulting in a 33.71% surprise. The estimated earnings for the next quarter are 30.10 INR per share. See more details about Divi's Laboratories Limited earnings.
Divi's Laboratories Limited revenue for the last quarter amounts to ‪30.80 B‬ INR, despite the estimated figure of ‪27.81 B‬ INR. In the next quarter, revenue is expected to reach ‪30.05 B‬ INR.
DIVISLAB net income for the last quarter is ‪9.02 B‬ INR, while the quarter before that showed ‪7.51 B‬ INR of net income which accounts for 0.00% change. Track more Divi's Laboratories Limited financial stats to get the full picture.
Yes, DIVISLAB dividends are paid annually. The last dividend per share was 30.00 INR. As of today, Dividend Yield (TTM)% is 0.32%. Tracking Divi's Laboratories Limited dividends might help you take more informed decisions.
Divi's Laboratories Limited dividend yield was 0.50% in 2025, and payout ratio reached 31.01%. The year before the numbers were 0.52% and 36.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 8, 2026, the company has ‪19.29 K‬ employees. See our rating of the largest employees — is Divi's Laboratories Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Divi's Laboratories Limited EBITDA is ‪39.67 B‬ INR, and current EBITDA margin is 32.98%. See more stats in Divi's Laboratories Limited financial statements.
Like other stocks, DIVISLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Divi's Laboratories Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Divi's Laboratories Limited technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Divi's Laboratories Limited stock shows the strong buy signal. See more of Divi's Laboratories Limited technicals for a more comprehensive analysis.